Virtus ETF Advisers’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-414
| Closed | -$13.2K | – | 453 |
|
|
2023
Q3 | $13.2K | Sell |
414
-41
| -9% | -$1.3K | 0.01% | 432 |
|
|
2023
Q2 | $37.5K | Sell |
455
-112
| -20% | -$9.22K | 0.02% | 433 |
|
|
2023
Q1 | $58.2K | Sell |
567
-218
| -28% | -$22.4K | 0.03% | 424 |
|
|
2022
Q4 | $115K | Sell |
785
-617
| -44% | -$90.4K | 0.06% | 429 |
|
|
2022
Q3 | $237K | Buy |
1,402
+10
| +0.7% | +$1.69K | 0.09% | 297 |
|
|
2022
Q2 | $161K | Buy |
1,392
+260
| +23% | +$30.1K | 0.06% | 314 |
|
|
2022
Q1 | $113K | Sell |
1,132
-67
| -6% | -$6.69K | 0.05% | 282 |
|
|
2021
Q4 | $186K | Buy |
1,199
+632
| +111% | +$98K | 0.07% | 236 |
|
|
2021
Q3 | $134K | Sell |
567
-29
| -5% | -$6.85K | 0.06% | 359 |
|
|
2021
Q2 | $203K | Buy |
596
+125
| +27% | +$42.6K | 0.08% | 335 |
|
|
2021
Q1 | $190K | Buy |
471
+9
| +2% | +$3.63K | 0.08% | 332 |
|
|
2020
Q4 | $308K | Sell |
462
-157
| -25% | -$105K | 0.13% | 201 |
|
|
2020
Q3 | $288K | Sell |
619
-84
| -12% | -$39.1K | 0.15% | 232 |
|
|
2020
Q2 | $411K | Buy |
+703
| New | +$411K | 0.19% | 188 |
|